Abstract 3262
Background
The characterization of adaptive immunity in the tumor microenvironment of non small cell lung cancer (NSCLC) is considered of outmost importance for the stratification of patients for immunotherapeutic approaches. For this, simple, feasible, inexpensive, reproducible and pathology based methodologies are needed, such as the evaluation of routine H&E stained slides, an approach that has been recently used for the interpretation of the immune-related pathologic response in the neoadjuvant immunotherapy setting.
Methods
We aimed to determine the prognostic significance of intratumoral and peritumoral tertiary lymphoid structures (TLS), plasma cells (PCs) and necrosis in a series of 140 patients with early stage, surgically resectable NSCLC. The evaluation of TLS (3-tiered score), PCs (4-tiered score) and necrosis (absent, focal, diffuse) was performed in hematoxylin-eosin (H&E) sections from surgical specimens of pulmonary wedge resection, lobectomy or pneumonectomy. Epidemiological data have been retrieved for 76 patients so far.
Results
In most of the tumors examined, presence of TLS and aggregates of PCs was noted (91% and 75%, respectively). The presence and density of TLS and PCs in the tumor microenvironment correlated with improved survival (p < 0.001 and p = 0.002 respectively, Kaplan-Meier). The presence of TLS also correlated positively with PC infiltrates (p < 0.001, CC = 0.644, Spearman). Importantly, all patients with diffuse large PCs aggregates (score 3) are alive for the follow-up period. On the contrary, the presence of diffuse necrosis proved to have an adverse effect on overall survival (p = 0.004, Kaplan-Meier) and showed no significant correlation with the presence of TLS and PCs.
Conclusions
The presence of elements of the adaptive immunity such as TLS and plasma cells is closely linked to clinical outcome in NSCLC. As plasma cell differentiation in the tumor environment correlated with the presence of TLS, this effector humoral immunity cell type might represent a surrogate marker of an effective immune response in the tumor microenvironment driven by the formation of Tertiary Lymphoid Structures.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
4925 - Prognostic role of CD73 in metastatic Non Small Cell Lung Cancer according to the presence of driver alterations
Presenter: Giulia Galli
Session: Poster Display session 1
Resources:
Abstract
785 - JAK-STAT inhibitor overcomes interferon γ-reduced, NK cell-mediated cytotoxicity in non-small-cell lung cancer cells
Presenter: Riki Okita
Session: Poster Display session 1
Resources:
Abstract
2326 - Low LATS2 expression is associated with poor prognosis in non small cell lung cancer
Presenter: Si-hyong Jang
Session: Poster Display session 1
Resources:
Abstract
5960 - Application of ESCAT and OncoKB scales in Liquid biopsy (LB) in Advanced NSCLC patients (pts): Is it feasible and reliable?
Presenter: Michael McCusker
Session: Poster Display session 1
Resources:
Abstract
4855 - IDH1R132H mutation induces a less aggressive phenotype of glioma cells and affects the radiosensitivity by interacting with Wnt/β-catenin signaling
Presenter: Xuetao Han
Session: Poster Display session 1
Resources:
Abstract
2641 - Impact of Angiopoietin-2 on glioblastoma response to combined chemo-radiotherapy
Presenter: Charly Helaine
Session: Poster Display session 1
Resources:
Abstract
5743 - The Discovery of RNA-aptamers That Selectively Bind and Inhibit Glioblastoma Stem Cells by targeting EphA2
Presenter: Alessandra Affinito
Session: Poster Display session 1
Resources:
Abstract
4160 - Impact of tumor reoxygenation by nanoparticles on Tumor Associated Macrophages (TAMs)
Presenter: Aurélie Ferré
Session: Poster Display session 1
Resources:
Abstract
2474 - Prognostic significance of c-Rel/p50 heterodimer in the tumor microenvironment of uveal melanoma
Presenter: Seema Kashyap
Session: Poster Display session 1
Resources:
Abstract
1769 - Synergistic role of BAP1 and DNA damage response pathway in uveal melanoma and its prognostic significance.
Presenter: JAYANTI JHA
Session: Poster Display session 1
Resources:
Abstract